General Info
Samjin Pharmaceutical is a company that pioneeres a healthy life for human beings with a creative mind and advances for a prosperous future.
Location: Mapo
Country:
Industries:
Investment Regions: SEA
Investment Stages: late-stage, seed, series-a
Website: http://www.samjinpharm.co.kr/
SEA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: Search results found a reported strategic investment by Samjin Pharmaceutical in Neurophet (뉴로핏) in February 2024 (reported July 19, 2024). From that investment date to the reference date, the elapsed time is between 12 and 21 months; specifically February 2024 is more than 12 months before the reference date, so classification would be ‘not-active’. However, additional sources (Tracxn snippet) indicate a more recent single investment entry (NEUROPHET) and news of activity in 2025 regarding selection for a government project; no confirmed investment after February 2024 was found. Given the last confirmed investment date of February 2024, the correct tag is ‘not-active’.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Samjin Pharmaceutical

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
